Point72 Asia (Singapore)’s Centessa Pharmaceuticals CNTA Stock Holding History

Point72 Asia (Singapore)’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$162K	Buy	+6,690	New	+$119K	0.03%	345

Other funds holding CNTA

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

IVLAV

Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Point72 Asia (Singapore)'s CNTA Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Centessa Pharmaceuticals (CNTA) in Q3 2025: 6,690 shares worth $162K. The stake represents 0.03% of the portfolio and ranks #345 among its holdings.

125 funds tracked by Wall St. Rank hold CNTA as of Q3 2025.

Point72 Asia (Singapore) held 6,690 shares of Centessa Pharmaceuticals worth $162K as of Q3 2025.
Centessa Pharmaceuticals was a new Point72 Asia (Singapore) position in Q3 2025.
Centessa Pharmaceuticals made up 0.03% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #345 holding.
125 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.